Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
-
Groups target EU-Mercosur FTA to advance access to health in trade deals
Interview NewsAIDS activists, health activists and civil society organizations in Brazil and Argentina are pushing back against the negative effects of...
Read more about Groups target EU-Mercosur FTA to advance access to health in trade deals
-
Collective efforts by civil society groups bar the way to Hepatitis C patents
NewsMany hold the view that Gilead’s revolutionary treatment against hepatitis C (sofosbuvir) marked the beginning of a shift in position...
Read more about Collective efforts by civil society groups bar the way to Hepatitis C patents
-
Truvada case shows civil society’s success with pre-grant opposition
NewsThe example of Gilead antiretroviral Truvada in Argentina and Brazil shows how civil society efforts to use patent opposition to...
Read more about Truvada case shows civil society’s success with pre-grant opposition
-
Thailand: Evergreened patents cause unwarranted high drug prices
Interview NewsTransnational drug manufacturers’ tactics of obtaining unmerited patent applications have unnecessarily raised healthcare costs and impeded the growth of domestic...
Read more about Thailand: Evergreened patents cause unwarranted high drug prices
-
Civil society key in TRIPS flexibility implementation
NewsCivil society plays an instrumental role in actively defending access to affordable to medicines, making use of TRIPS flexibilities, and...
Read more about Civil society key in TRIPS flexibility implementation
-
Launched: I-MAK’s Special Edition Roadmap on Tenofovir Alafenamide Fumarate (TAF)
NewsA critical analysis of TAF, as part of a Roadmap series, aims to help the international community assess the best...
Read more about Launched: I-MAK’s Special Edition Roadmap on Tenofovir Alafenamide Fumarate (TAF)
-
Gilead’s patent application on sofosbuvir rejected in Brazil
NewsRejected! That was the decision issued by Brazil’s National Institute of Industrial Property (INPI) over one of Gilead’s patent applications...
Read more about Gilead’s patent application on sofosbuvir rejected in Brazil
-
Ukraine eyes patent law reform after civil society push on medicines access
NewsUkrainian lawmakers are poised to approve sweeping patent reform legislation, driven in large part by a push by patients’ groups...
Read more about Ukraine eyes patent law reform after civil society push on medicines access
-
ADVOCATES PUBLISH COMMENTARY ON EXPANDING TREATMENT ACCESS FOR VIRAL HEPATITIS C
NewsOn 2 April 2018, an in-depth commentary on practical actions that can help increase access to HCV direct-action antivirals (DAAs)...
Read more about ADVOCATES PUBLISH COMMENTARY ON EXPANDING TREATMENT ACCESS FOR VIRAL HEPATITIS C
-
Botswana: Creating (radio) waves to show how intellectual property affects us all
NewsBONELA is raising national awareness as to why intellectual property (IP) and access to medicines are relevant for everyone –...
Read more about Botswana: Creating (radio) waves to show how intellectual property affects us all